Abstract
Introduction
Spindle cell oncocytoma (SCO) is an extremely rare sellar neoplasm. No observational studies have been reported so far to investigate the prognostic factors of this tumor entity. This systematic review aimed to elucidate the risk factors for tumor recurrence/progression of SCO.
Methods
We searched for relevant articles in PubMed and Web of Science. Studies providing individual patient data with follow-up information of SCO cases were included. Pearson’s Chi square and Fisher’s exact test were used for categorical variables while t test or Mann–Whitney tests were applied for continuous variables, if applicable. We used the Cox regression model to assess the effects of suspected variables on progression-free survival (PFS).
Results
A total of 38 case reports and case series comprising of 67 SCOs were included for final analyses. Recurrent/progressive tumors were noted in 38.8% of cases. Among the clinicopathological factors, only the extent of surgery was a significant risk factor for tumor recurrence/progression. SCO patients with a subtotal resection had a significantly higher risk for tumor relapse in comparison with complete removal (HR 7.51; 95% CI 1.75–32.31; p = 0.007).
Conclusion
Our study demonstrated the characteristic clinicopathological features of SCOs with a high recurrence/progression rate and outlined the predictor for tumor relapse. Failure to achieve gross total resection is the only risk factor for tumor recurrence/progression.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- GTR:
-
Gross total resection
- IPD:
-
Individual patient data
- HR:
-
Hazard ratio
- PFS:
-
Progression-free survival
- SCO:
-
Spindle cell oncocytoma
- STR:
-
Subtotal resection
- TCR:
-
Transcranial resection
- TSR:
-
Transsphenoidal resection
- TTF-1:
-
Thyroid transcription factor-1
- WHO:
-
World Health Organization
References
Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS (2019) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro-oncology 21(Suppl 5):v1–v100. https://doi.org/10.1093/neuonc/noz150
Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382(10):937–950. https://doi.org/10.1056/NEJMra1810772
Melmed S (2016) Pituitary medicine from discovery to patient-focused outcomes. J Clin Endocrinol Metab 101(3):769–777. https://doi.org/10.1210/jc.2015-3653
Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516–524. https://doi.org/10.1001/jama.2016.19699
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
Roncaroli F, Scheithauer BW, Cenacchi G, Horvath E, Kovacs K, Lloyd RV, Abell-Aleff P, Santi M, Yates AJ (2002) ‘Spindle cell oncocytoma’ of the adenohypophysis: a tumor of folliculostellate cells? Am J Surg Pathol 26(8):1048–1055
Alexandrescu S, Brown RE, Tandon N, Bhattacharjee MB (2012) Neuron precursor features of spindle cell oncocytoma of adenohypophysis. Ann Clin Lab Sci 42(2):123–129
Hagel C, Buslei R, Buchfelder M, Fahlbusch R, Bergmann M, Giese A, Flitsch J, Ludecke DK, Glatzel M, Saeger W (2017) Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells. Pituitary 20(2):211–217. https://doi.org/10.1007/s11102-016-0762-x
Vuong HG, Kondo T, Tran TM, Oishi N, Nakazawa T, Mochizuki K, Inoue T, Kasai K, Tahara I, Jieying W, Katoh R (2016) Spindle cell oncocytoma of adenohypophysis: report of a case and immunohistochemical review of literature. Pathol Res Pract 212(3):222–225. https://doi.org/10.1016/j.prp.2015.07.014
Coiré CI, Horvath E, Smyth HS, Kovacs K (2009) Rapidly recurring folliculostellate cell tumor of the adenohypophysis with the morphology of a spindle cell oncocytoma: case report with electron microscopic studies. Clin Neuropathol 28(4):303–308. https://doi.org/10.5414/npp28303
Guadagno E, Cervasio M, Di Somma A, Califano M, Solari D, De Caro MD (2016) Essential role of ultrastructural examination for spindle cell oncocytoma: case report of a rare neoplasm and review of the literature. Ultrastruct Pathol 40(2):121–124. https://doi.org/10.3109/01913123.2016.1157662
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097
Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60–63. https://doi.org/10.1136/bmjebm-2017-110853
Akyoldaş G, Hergünsel ÖB, Özdemir İE, Şengöz M, Peker S (2019) Gamma knife radiosurgery for pituitary spindle cell oncocytomas. Clin Neurol Neurosurg 187:105560. https://doi.org/10.1016/j.clineuro.2019.105560
Billeci D, Marton E, Giordan E, Carraro V, Ronzon M, Rossi S (2017) Spindle cell oncocytoma: report of two cases with massive bleeding and review of the literature. J Clin Neurosci 39:39–44. https://doi.org/10.1016/j.jocn.2017.02.017
Borg A, Jaunmuktane Z, Dorward N (2020) Tumors of the neurohypophysis: one unit’s experience and literature review. World Neurosurgery 134:E968–E978. https://doi.org/10.1016/j.wneu.2019.11.043
Borges MT, Lillehei KO, Kleinschmidt-DeMasters BK (2011) Spindle cell oncocytoma with late recurrence and unique neuroimaging characteristics due to recurrent subclinical intratumoral bleeding. J Neurooncol 101(1):145–154. https://doi.org/10.1007/s11060-010-0229-2
Borota OC, Scheithauer BW, Fougner SL, Hald JK, Ramm-Pettersen J, Bollerslev J (2009) Spindle cell oncocytoma of the adenohypophysis: report of a case with marked cellular atypia and recurrence despite adjuvant treatment. Clin Neuropathol 28(2):91–95
Custodio PJP, Jho DH, Pu C, Gordon MB, Donangelo I (2015) Spindle cell oncocytoma of the pituitary presenting with severe hyponatremia. AACE Clin Case Rep 2(3):e237–e243. https://doi.org/10.4158/EP15941.CR
Dahiya S, Sarkar C, Hedley-Whyte ET, Sharma MC, Zervas NT, Sridhar E, Louis DN (2005) Spindle cell oncocytoma of the adenohypophysis: report of two cases. Acta Neuropathol 110(1):97–99. https://doi.org/10.1007/s00401-005-1009-5
Demssie YN, Joseph J, Dawson T, Roberts G, de Carpentier J, Howell S (2011) Recurrent spindle cell oncocytoma of the pituitary, a case report and review of literature. Pituitary 14(4):367–370. https://doi.org/10.1007/s11102-009-0170-6
Fujisawa H, Tohma Y, Muramatsu N, Kida S, Kaizaki Y, Tamamura H (2012) Spindle cell oncocytoma of the adenohypophysis with marked hypervascularity. Case report. Neurol Med Chir 52(8):594–598. https://doi.org/10.2176/nmc.52.594
Gupta RK, Batra VV, Singh D, Sharma MC, Kumar V (2018) Is spindle cell oncocytoma a true entity or a variant of pituicytoma? A case report with review of literature. Neurol India 66(5):1413–1418. https://doi.org/10.4103/0028-3886.241353
Hasiloglu ZI, Ure E, Comunoglu N, Tanriover N, Oz B, Gazioglu N, Mihmanli I (2016) New radiological clues in the diagnosis of spindle cell oncocytoma of the adenohypophysis. Clin Radiol. https://doi.org/10.1016/j.crad.2016.04.022
Kloub O, Perry A, Tu PH, Lipper M, Lope MBS (2005) Spindle cell oncocytoma of the adenohypophysis—report of two recurrent coses. Am J Surg Pathol 29(2):247–253. https://doi.org/10.1097/01.pas.0000147400.87767.f6
Kong X, Li D, Kong Y, Zhong D (2017) Malignant adenohypophysis spindle cell oncocytoma with repeating recurrences and a high Ki-67 index. Medicine 96(4):e5657. https://doi.org/10.1097/md.0000000000005657
Larsen AMG, Cote DJ, Zaidi HA, Bi WL, Schmitt PJ, Iorgulescu JB, Miller MB, Smith TR, Lopes MB, Jane JA, Laws ER (2019) Spindle cell oncocytoma of the pituitary gland. J Neurosurg 131(2):517–525. https://doi.org/10.3171/2018.4.jns18211
Manoranjan B, Koziarz A, Kameda-Smith MM, Provias JP (2017) Multiple recurrences require long-term follow-up in patients diagnosed with spindle cell oncocytoma of the sella turcica. J Clin Neurosci 43:134–146. https://doi.org/10.1016/j.jocn.2017.05.017
Mathkour M, Garces J, Sculen T, Vale-Giler E, Halat S, Arington T, Ware M (2017) Spindle cell oncocytoma of the pituitary gland. J Neurosurg Sci 61(5):554–557. https://doi.org/10.23736/s0390-5616.16.03433-0
Matyja E, Maksymowicz M, Grajkowska W, Olszewski W, Zielinski G, Bonicki W (2010) Spindle cell oncocytoma of the adenohypophysis—a clinicopathological and ultrastructural study of two cases. Folia Neuropathol 48(3):175–184
Mlika M, Azouz H, Chelly I, Saïd IB, Jemel H, Haouet S, Zitouna M, Kchir N (2011) Spindle cell oncocytoma of the adenohypophysis in a woman: a case report and review of the literature. J Med Case Rep 5:64. https://doi.org/10.1186/1752-1947-5-64
Mu Q, Yu J, Qu L, Hu X, Gao H, Liu P, Zheng X, Sun Y, Huang H (2015) Spindle cell oncocytoma of the adenohypophysis: two case reports and a review of the literature. Mol Med Rep 12(1):871–876. https://doi.org/10.3892/mmr.2015.3476
Ogiwara H, Dubner S, Shafizadeh S, Raizer J, Chandler JP (2011) Spindle cell oncocytoma of the pituitary and pituicytoma: two tumors mimicking pituitary adenoma. Surg Neurol Int 2:116. https://doi.org/10.4103/2152-7806.83932
Osman M, Wild A (2017) Spindle cell oncocytoma of the anterior pituitary presenting with an acute clinical course due to intraventricular hemorrhage. A case report and review of literature. Am J Case Rep 18:894–901
Oushy S, Graffeo CS, Perry A, Stafford SL, Link MJ, Pollock BE (2019) Single-fraction stereotactic radiosurgery for spindle cell oncocytoma: preliminary experience and systematic review of the literature. J Neurooncol 144(2):325–332. https://doi.org/10.1007/s11060-019-03231-x
Saito R, Jinguji S, Taniguchi Y, Takeuchi S, Okamoto K, Nishizawa M, Takahashi H, Kakita A (2016) Nonfunctional intra- and suprasellar tumor in a patient with visual disturbance and panhypopituitarism. Neuropathology 36(1):107–112. https://doi.org/10.1111/neup.12236
Sali A, Epari S, Tampi C, Goel A (2017) Spindle cell oncocytoma of adenohypophysis: review of literature and report of another recurrent case. Neuropathology 37(6):535–543. https://doi.org/10.1111/neup.12393
Samadian M, Mousavinejad SA, Khoshsirat S, Dehghan M, Sharifi G, Ebrahimzadeh K, Rezaei O (2020) Trans-nasal trans-sphenoidal endoscopic resection of spindle cell oncocytoma of adenohypophysis: the first case report in a child and a review of literature. Asian J Neurosurg 15(1):210–213. https://doi.org/10.4103/ajns.AJNS_166_19
Singh G, Agarwal S, Sharma MC, Suri V, Sarkar C, Garg A, Kale SS (2012) Spindle cell oncocytoma of the adenohypophysis: report of a rare case and review of literature. Clin Neurol Neurosurg 114(3):267–271. https://doi.org/10.1016/j.clineuro.2011.10.014
Sollfrank L, Lettmaier S, Erdmann M, Uslu U (2019) Panniculitis under successful targeted inhibition of the MAPK/ERK signaling pathway in a patient with BRAF V600E-mutated spindle cell oncocytoma of the pituitary gland. Anticancer Res 39(7):3955–3959. https://doi.org/10.21873/anticanres.13549
Sosa S, Danilowicz K, Abbati SG, Sevlever G (2018) Pituitary spindle cell oncocytoma. Med Buenos Aires 78(1):33–36
Soukup J, Kasparova P, Kohout A, Rychly B, Skarkova V, Syrucek M, Gabalec F (2019) Evaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary. Pituitary 22(1):70–78. https://doi.org/10.1007/s11102-018-00935-7
Vajtai I, Sahli R, Kappeler A (2006) Spindle cell oncocytoma of the adenohypophysis: report of a case with a 16-year follow-up. Pathol Res Pract 202(10):745–750. https://doi.org/10.1016/j.prp.2006.05.008
Witte HM, Riecke A, Saeger W, Hackenbroch C, Mathieu R, Mauer UM, Schulz C (2018) Spindle cell oncocytoma of the neurohypophysis with metastasis to the sphenoparietal sinus and immunohistochemical negativity for S100 and epithelial membrane antigen (EMA). Br J Neurosurg. https://doi.org/10.1080/02688697.2018.1533107
Wu CY, Wang J, Yang CS, Lee FY, Jan YJ (2016) A 55-year-old male with a pituitary tumor. Brain Pathol 26(3):419–420. https://doi.org/10.1111/bpa.12378
Zygourakis CC, Rolston JD, Lee HS, Partow C, Kunwar S, Aghi MK (2015) Pituicytomas and spindle cell oncocytomas: modern case series from the University of California, San Francisco. Pituitary 18(1):150–158. https://doi.org/10.1007/s11102-014-0568-7
Cote DJ, Wiemann R, Smith TR, Dunn IF, Al-Mefty O, Laws ER (2015) The expanding spectrum of disease treated by the transnasal, transsphenoidal microscopic and endoscopic anterior skull base approach: a single-center experience 2008-2015. World Neurosurg 84(4):899–905. https://doi.org/10.1016/j.wneu.2015.05.019
Louis DN, Perry A, Reifenberger G, Von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820
Lee EB, Tihan T, Scheithauer BW, Zhang PJ, Gonatas NK (2009) Thyroid transcription factor 1 expression in sellar tumors: a histogenetic marker? J Neuropathol Exp Neurol 68(5):482–488. https://doi.org/10.1097/NEN.0b013e3181a13fca
Mete O, Lopes MB, Asa SL (2013) Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma. Am J Surg Pathol 37(11):1694–1699. https://doi.org/10.1097/PAS.0b013e31829723e7
Rim CH, Yang DS, Park YJ, Yoon WS, Lee JA, Kim CY (2011) Radiotherapy for pituitary adenomas: long-term outcome and complications. Radiat Oncol J 29(3):156–163. https://doi.org/10.3857/roj.2011.29.3.156
Witt TC (2003) Stereotactic radiosurgery for pituitary tumors. Neurosurg Focus 14(5):e10. https://doi.org/10.3171/foc.2003.14.5.11
Miller MB, Bi WL, Ramkissoon LA, Kang YJ, Abedalthagafi M, Knoff DS, Agarwalla PK, Wen PY, Reardon DA, Alexander BM, Laws ER, Dunn IF, Beroukhim R, Ligon KL, Ramkissoon SH (2016) MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma. Oncotarget 7(24):37054–37063. https://doi.org/10.18632/oncotarget.9244
Vuong HG, Altibi AMA, Duong UNP, Ngo HTT, Pham TQ, Fung KM, Hassell L (2018) BRAF mutation is associated with an improved survival in glioma-a systematic review and meta-analysis. Mol Neurobiol 55(5):3718–3724. https://doi.org/10.1007/s12035-017-0599-y
Xie J, Silverman JF, Pu C, Graner S, Storto P, Donangelo I, Jasnosz KM (2017) Spindle cell oncocytoma of adenohypophysis: cytogenetics and β-catenin findings with pathology differential diagnosis and review of the literature. Human Pathol: Case Rep 9:71–75. https://doi.org/10.1016/j.ehpc.2016.08.004
Funding
This study receives no funding support.
Author information
Authors and Affiliations
Contributions
HGV: conceptualization, data curation, formal analysis, investigation, methodology, project administration, software, validation, supervision, writing-review, and editing. TPXN: data curation, formal analysis, investigation, software, supervision, writing-review, and editing. NP: data curation, formal analysis, investigation, validation, supervision, writing-review, and editing. IFD: conceptualization, data curation, formal analysis, investigation, methodology, project administration, software, validation, supervision, writing-review, editing, and supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Vuong, H.G., Nguyen, T.P.X., Pham, N. et al. Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis. Pituitary 24, 429–437 (2021). https://doi.org/10.1007/s11102-020-01110-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-020-01110-7